NCOMS has access to oncology leaders with every specialty and has legislative influence at the state and federal level. As part of this committee, these representatives hold an invaluable seat at the table to represent their employers, the industry, and drive positive industry change. They also gain invaluable insights into the evolving landscape of oncology managerial needs. Through this committee, they can ensure their research, development, and commercialization efforts are on the forefront of care trends and their priorities in line with those of statewide oncology executives.

Ultimately, the partnership between life science and pharmaceutical companies and NCOMS serves as a powerful catalyst for progressing cancer care and practice and system profitability.